IOM: Tracking system needed to curb sales of fake drugs

02/13/2013 | CBS News

The Institute of Medicine has called for a national drug-tracking system following an FDA warning on counterfeit Avastin. Such a system might utilize barcodes or electronic tags to confirm the authenticity of a medication and the ingredients used during its production, an expert said. FDA Commissioner Dr. Margaret Hamburg lauded the report.

View Full Article in:

CBS News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Sr. Compliance Director Ethics and Compliance
Medtronic
Fridley, MN
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC